Detalhe da pesquisa
1.
Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.
PLoS Pathog
; 10(5): e1004085, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24788397
2.
Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis.
PLoS Negl Trop Dis
; 13(8): e0007644, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31430284